1. Home
  2. SAGE vs CLW Comparison

SAGE vs CLW Comparison

Compare SAGE & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • CLW
  • Stock Information
  • Founded
  • SAGE 2010
  • CLW 2005
  • Country
  • SAGE United States
  • CLW United States
  • Employees
  • SAGE N/A
  • CLW N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • CLW Paper
  • Sector
  • SAGE Health Care
  • CLW Basic Materials
  • Exchange
  • SAGE Nasdaq
  • CLW Nasdaq
  • Market Cap
  • SAGE 413.9M
  • CLW 458.4M
  • IPO Year
  • SAGE 2014
  • CLW N/A
  • Fundamental
  • Price
  • SAGE $9.30
  • CLW $26.41
  • Analyst Decision
  • SAGE Hold
  • CLW Buy
  • Analyst Count
  • SAGE 18
  • CLW 1
  • Target Price
  • SAGE $10.06
  • CLW $37.00
  • AVG Volume (30 Days)
  • SAGE 2.4M
  • CLW 179.9K
  • Earning Date
  • SAGE 07-30-2025
  • CLW 08-05-2025
  • Dividend Yield
  • SAGE N/A
  • CLW N/A
  • EPS Growth
  • SAGE N/A
  • CLW 73.65
  • EPS
  • SAGE N/A
  • CLW 10.33
  • Revenue
  • SAGE $47,404,000.00
  • CLW $1,503,000,000.00
  • Revenue This Year
  • SAGE $102.21
  • CLW $15.71
  • Revenue Next Year
  • SAGE $43.01
  • CLW $1.44
  • P/E Ratio
  • SAGE N/A
  • CLW $2.48
  • Revenue Growth
  • SAGE N/A
  • CLW 72.88
  • 52 Week Low
  • SAGE $4.62
  • CLW $22.58
  • 52 Week High
  • SAGE $13.47
  • CLW $57.13
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 78.92
  • CLW 36.86
  • Support Level
  • SAGE $6.44
  • CLW $27.44
  • Resistance Level
  • SAGE $9.33
  • CLW $29.46
  • Average True Range (ATR)
  • SAGE 0.26
  • CLW 0.81
  • MACD
  • SAGE 0.33
  • CLW -0.41
  • Stochastic Oscillator
  • SAGE 98.98
  • CLW 0.00

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: